TOVX Acquisition: a positive outcome, +5.9%

On November 2, 2026, Theriva Biologics, Inc. reached its Acquisition. The result was a positive outcome, and the stock moved +5.9% in the window around the event. It had already run -26.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.